We found that, overall, participants from the new dataset had significantly lower TBR, TIR, GRI and HbA1c, more frequently used pumps and automated insulin delivery systems and had less frequent retinopathy and neuropathy (ESM Table 5). The gene discussed is INS; the disease is neuropathy.